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ABSTRACT
Background: Infections are caused by Bovine Viral Diarrhea Virus and still continue to be a worldwide plague in cattle 
industry. It is responsible for sudden death syndromes in adult cattle with high mortality rates, abortions, acute gastrointes-
tinal and respiratory diseases. The BVDV infection occurs in early pregnancy (40-142 days), in immunosuppressed females 
or cows results in 100% of persistently infected (PI) calves that are seronegative and asymptomatic at birth. Evidences 
suggests that BVDV contributes to BRD complex potentiating secondary infections caused by Mannheimia haemolytica 
e Pasteurella multocida due to its immunosuppressive action. However, the farmers have often associated the respiratory 
syndrome with other infectious agents. This paper reports the attendance of dairy calves manifesting clinical signs of bron-
chopneumonia, which led to the screening of the persistently infected animals to control of the BVDV infection in the herd. 
Materials, Methods & Results: During the technical assistance, ten calves manifesting bronchopneumonia were selected to 
trans-tracheal lavage (TL) in order to identify possible infectious agents. Reverse transcription polymerase chain reaction 
(RT-PCR) detected the presence of BVDV in two heifers. Pasteurella multocida was the unique bacterial agent isolated 
from TL (5/10, 50%). These data motivated the technical team and producers to investigate the PI screening by direct 
enzyme-linked immunosorbent assay from biopsies of the ear edge. The screening of PI’s detected 29 positive within of 
2,342 animals tested (1.23%). The re-test of positive was performed only in 24 animals due to the cull of five bovine with 
severe bronchopneumonia and diarrhea, confirming 18 persistently infected calves (18/24; 75%). Finally, in all PI’s live 
dams were tested. It was observed four positive adult animals. One grand dam was live and tested, but it had negative result 
for direct enzyme-linked immunosorbent test. The rate of PI’s considering the whole herd was 0.81% (22/3,700 animals). 
Discussion: The involvement of BVDV in the etiology of bronchopneumonia was confirmed by detection of the virus in 
trans-tracheal lavages in two calves by RT-PCR. The susceptibility for Pasteurella multocida infection could be promoted 
by BVDV prime-infection, considering that immunossupressive nature of BVDV is a critical factor in the interaction with 
others viruses and bacteria. At this time, we are aware about any report about the detection of BVDV in trans-tracheal 
lavages. These findings culminated with the screening of PI animals in the herd, detecting rates of 0.81%. 
The intensive vaccination and colostrum management of this farm could protected the herd against BVDV, however oth-
ers facts facilitated the introduction of the virus in the herd. This research was conduced in a high-production dairy farm 
with around 3,700 animals raised in an open herd, in which some of cows with high genetic potential were transferred 
for embryo collection in the state of Paraná, Brazil; resulting in the addition of the calves to the herd by others routes. 
Moreover, the farm used for many years vaccine containing only BVDV-1, which may have favored the entry and spread 
of BVDV-2 or BVDV-3 in the herd. This research showed the presence of BVDV in trans-tracheal lavage of heifers with 
bronchopneumonia by RT-PCR. This fact points to the need of BRD control programs that include detection of PI animals.
Keywords: RT- PCR, direct enzyme immunoassay test, Pasteurella multocida.
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INTRODUCTION
Infections are caused by Bovine Viral Diarrhea 
Virus and still continue to be a worldwide plague in 
cattle industry. It is responsible for sudden death syn-
dromes in adult cattle with high mortality rates, abor-
tions, acute gastrointestinal and respiratory diseases 
[12]. The economic losses for BVDV in the United 
States were estimated between U$ 460 up to 767 mil-
lion per year [7].
The BVDV belongs to Flaviviridae family 
and Pestivirus genus. This agent has ribonucleic acid 
as genetic material and it is classified in two biotypes, 
based on its ability to produce cytopathic effects in 
cell culture and genetic sequencing: non cytopatho-
genic (NCP) and cytopathogenic (CP), and genotypes: 
BVDV-1 and BVDV- 2. Moreover, Pestivirus atypical 
was isolated in Brazil some years ago in a fetal bovine 
serum sample and has been called as Hobi-like [2].
The BVDV infection in early pregnancy (40-
142 days), in immunosuppressed females or cows 
results in 100% of persistently infected (PI) calves. PI 
animals are seronegative and asymptomatic at birth, 
but they are constantly eliminating the virus in all its 
secretions and excretions [9,10].
Evidence suggests that BVDV contributes to 
BRD complex potentiating secondary infections caused 
by Mannheimia haemolytica and Pasteurella multocida 
due to its immunosuppressive action. This immuno-
suppression affects many different components of the 
innate system such as interferon production, phagocy-
tosis, chemotaxia, microbicidal activity. In relation to 
the specific immune system, BVDV CP and NCP can 
kill (by apoptosis) T and B cells in lymphoid tissues. 
There is negative effect of BVDV infection on T helper 
response. The activation of the T helper 2 responses 
by NCP BVDV provides another mechanism that also 
affects acquired and innate immunity. The helper 2 
response suppresses the T helper 1 memory response 
and also suppresses the phagocytic and microbicidal 
activity of macrophages. No one genotype (type 1 
vs. type 2) or biotype (noncytophatic vs. cytophatic) 
produces the same effects on the immune system. 
This immunosuppression can last up 3-4 weeks. Both 
humoral and cellular mediate immune responses are 
important in the BVDV infection [3,4].
The unspecific symptomatology of BVDV is 
the first challenge to prove the impact of the virus infec-
tion in the production system, because the producers 
often associated the syndrome caused by BVDV with 
other infectious agents. So, farmers do not investigate 
PI’s screening. In Brazil, it is more serious due to the 
inexistence of an official program for BVDV control. 
These facts were the motivation for the description of a 
practical work realized in the biggest dairy farm located 
in the countryside of São Paulo state. This work cul-
minated with the consciousness of the technical team 
and producer to proceed with PI screening in the herd.
This paper reports the attendance of dairy 
calves manifesting clinical signs of bronchopneu-
monia, which led to the screening of the persistently 
infected animals to control the BVDV infection in the 
herd. 
MATERIALS AND METHODS
Herd identification and installations
This work was conduced in a commercial 
dairy herd of high production, average of 66,000 L of 
milk/day, located in the countryside of Sao Paulo. The 
herd consists of approximately 3,700 Holstein cows, 
of which 1,750 were dairy cows with average daily 
production of 38.5 L. Suckler heifers aged from 1 to 
60 days, approximately 95 animals, were housed in 
individual suspended cages with approximately 1 m2, 
distributed in covered shed with an area of 112.5 m2 
and a height of 4.5 m (1.18 unit animal/m2). After this 
period, animals were moved to confinement pasture and 
remained until 30 days of the expected day and then 
they were transferred to the maternity pasture. Dairy 
cows were housed in the shed with cross ventilation 
system. During the dry period, the animals were kept 
in barns of the free-stall type.
The births were assisted and calves were 
separated immediately after calving and transferred to 
individual pen. Four L of colostrum of the first milk-
ing were administered into 2 feedings during the first 
12 h after birth. The colostrum was from multiparous 
donors, whose immune quality was estimated by co-
lostrometer (≥50 g/L of immunoglobulin). The thaw-
ing was performed in a water bath (45-50°C) until the 
colostrum reach 37°C. Then, calves were fed with 6 
L of milk replacer per day.
The farm vaccination protocol begins at the 
creating stage by 60 days of life and the animals receive 
booster at 90 days, followed by semiannual revac-
cination held in April and October. The commercial 
vaccine used contains inactivated strains of BVDV 
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type 1; BHV-1 and PI-3; BRSV, and Leptospira spp., 
associated with aluminum hydroxide as adjuvants.
Approach of calves with bronchopneumonia
The first technical visit in this farm was real-
ized in August 2013. The technical team from farm 
requested clinical assistance due to the high incidence 
of bronchopneumonia and failure in the treatment with 
antibiotics.
First of all, 10 heifers manifesting broncho-
pneumonia, between 45 to 60 days of life, were selected 
to procedure clinical examination and laboratorial 
exams. Bronchopneumonia was scored using the fol-
lowing parameters: rectal temperature, cough, nasal 
and ocular secretion and ear position with a score of 
0-3 for each based on severity. Calves were assessed 
as having bronchopneumonia when the sum of these 
scores was > 5. Bronchopneumonia scores in according 
to Calf Heath Scoring Criteria previously published by 
The University of Wisconsin (Madison) [14].
Trans-tracheal lavage was obtained by punctur-
ing the trachea in its middle third, with a trocar of 2.1 
mm diameter and 5.1 cm length, in which was inserted 
a polyethylene catheter of 1.7 mm x 20.3 cm (Intracath, 
BD). Then, 40 mL of 0.9% saline were instilled into 
the trachea and the contents were immediately recov-
ered by aspiration with a syringe. The samples were 
placed in 2 sterile tubes for bacteriological and reverse 
transcription polymerase chain reaction.
Serum samples were used for detection of 
neutralizing antibodies to Bovine Respiratory Syncytial 
Virus (BRSV), BVDV and Bovine Herpesvirus type 1 
(BHV-1) by VN in accordance to OIE (2015). 
Trans-tracheal lavage was inoculated in Brain 
Heart Infusion (BHI), blood agar (5%) and MacCon-
key, incubated at 37ºC for 24 to 48 h [15]. Susceptibil-
ity test was performed in vitro to antibiotics [1].
For RT-PCR, the RNA extracted in trans-
tracheal lavage was tested using TRIZOL LS® (Invit-
rogen1). Reverse transcription followed by polymerase 
chain reaction was performed according to the manu-
facturer’s recommendations (Accessquick PCR Master 
mix®, PROMEGA2). The primers used in the reaction 
detected common regions for BVDV 1, 2 and Hobi-
like, based on a sequence of 290 nucleotides, located 
in the 5’ non-translated region (5’ TAG CCA TGC CCT 
TAG TAG GAC 3’ e 5’ ACT CCA TGT GCC ATG TAC 
AGC 3’) according Weinstock et al. [18]. Amplicons 
were detected by electrophoresis on 1.5% agarose gel 
stained by diluted GelRed4 (1:150) in nuclease free 
water. The visualization was performed using a transil-
luminator under ultraviolet light (320 nm). The DNA 
fragments were compared with the standard base pairs 
presenting increments of 100 pb (DNA Ladder of 100 
pb®, Invitrogen1). 
Detection of persistently infected (PI) animals
The evidences of the presence of BVDV in 
the first visit, associated to the high levels of specific 
antibodies in the bulk tank milk convinced the techni-
cal team from the farm and producers to invest in the 
detection of persistently infected (PI) animals. It was a 
long process between 2013 until 2015. The data from 
the first visit will be present in the appropriate topic.
The first visit for PI detection was realized in 
September 9th and 10th, 2013. Ear biopsy was performed 
in 2,342 animals, contemplating the latest generation 
of females, dairy cows that calved only male or those 
without living descendants. 
The re-tested in the positive or suspicious 
results in the direct enzyme immunoassay test were 
realized in October 13th, to distinguish between tran-
sient and persistent infection. In October 29th, dams 
(n = 4) and grand dam (n = 1) of PI animals were also 
submitted to the same protocol described previously.
The direct enzyme-linked immunosorbent as-
say was performed from biopsies of the ear edge. The 
fragment was obtained with approximately 1.0 cm 
long and 0.5 cm wide, using the ear notch biopsy and 
kept in microtubes. Among each harvest, the material 
was disinfected with 70% ethanol. The direct enzyme 
linked immunosorbent assay was performed using a 
commercial kit following the manufacturer’s instruc-
tions (Bovine Virus Diarrhoea Virus - Antigen Test 
Kit/Serum Plus®3).
RESULTS
The individual results obtained in the first 
visit performed in August/2013 with high rates of 
bronchopneumonia in calves are shown in the Table 
1. The minimum and maximum values of antibody 
titers oscillated from 4 to 512 for BHV-1; 40 to 5,120 
for BVDV; and 32 to 256 for BRSV. Moreover, RT-
PCR detected the presence of BVDV in trans-tracheal 
lavage from two heifers that presented titers of 40 and 
640 for BVDV, and only one of them had concomitant 
infection by Pasteurella multocida.
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Pasteurella multocida was the unique bacterial 
agent isolated from trans-tracheal lavage (5/10, 50%), 
observing resistance for the following antimicrobials: 
amikacin (30 μg), ampicillin (10 μg), amoxicillin + 
clavulanic acid (10 μg), gentamicin (10 μg), neomycin 
(30 μg) and trimethoprim + sulfamethoxazole (25 μg). 
On the other hand, it was possible to observe sensibility 
of strains for the following antimicrobials: cephalexin 
(30 μg), cephalothin (30 μg), cefoxitin (30 μg), ceftio-
fur (30 μg), ciprofloxacin (5 μg), enrofloxacin (5 μg), 
norfloxacin (10 μg) and tetracycline (30 μg).
The presence of BVDV in trans-tracheal lavage 
was the first motivation to perform the screening of PI 
in the herd. These results motivated the screening of 
PI’s animals in the herd.
The first test for BVDV, realized in 2013, 
September 9th and 10th, detected 1.24% (29/2,342) 
positives within 2,342 animals tested. The re-test of 
positive animals in October 12th, was performed only 
in 24 animals due to the cull of 5 bovine with severe 
bronchopneumonia and diarrhea, confirming 18 per-
sistently infected calves (18/24; 75%). Finally, all live 
dams of PI’s were tested, observing 4 positive adult 
animals (Table 2). One grand dam was also tested, but 
it had negative result for direct enzyme-linked immu-
nosorbent test. The rate of PI’s considering the whole 
herd was 0.81% (22/3,700 animals). 
It is worth emphasizing that one of the calves 
diagnosed with PI in the second stage had presented 
positive RT-PCR for BVDV in trans-tracheal lavage.





BHV-1 BVDV BRSV BVDV












2 4 640 128 Pasteurella multocida
3 512 5120 256 Pasteurella multocida
4 64 320 * Pasteurella multocida
5 8 40 128 Negative
6 256 80 32 Negative
7 64 1280 128 Pasteurella multocida
8 32 640 32 Negative
9 32 320 64 Pasteurella multocida
10 4 640 64 Negative
*Insufficient sample.
Table 2. Results obtained for PI’s screening in a dairy farm according to the Direct enzyme-linked immunosorbent assay.
Dates/2015 Number of tested animals Positive results Frequency (%)
Screening (September 9 and 10)* 2,342 29 1.24%
Re-test (October 13)** 24*** 18 75%
Dams test (October 29)**** 4 4 100%
Granddam (October 29)***** 1 0 0%
*For BVDV screening were tested the latest generation of females, dairy cows that calved only male or those without living descendants; **live positive 
animals were re-tested around 30 days after the screening; *** five animals were culled due to intense bronchopneumonia and diarrhea; ****live dams 
of PI’s were tested for BVDV; *****live granddam tested.
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DISCUSSION
This study initially was conducted according 
to the request of the producer with the initial objec-
tive was identify possible etiological agents involved 
in BRD due to its high incidence and rate of failure in 
treatment with antimicrobials. 
The main etiologic agents detected in trans-
tracheal lavage were BVDV associated with Pasteu-
rella multocida. The involvement of BVDV in BRD is 
consensual due to the detection of genetic material of 
this virus in trans-tracheal lavage from dead animals 
obtained in slaughterhouses or necropsies [5,19]. 
On the other hand, the identification of this agent 
in trans-tracheal lavage from live heifers presenting 
bronchopneumonia had not yet been reported. This 
method could be used to identify BVDV involvement 
in animals manifesting bronchopneumonia. It is be-
lieved the hypothesis that the sensitivity of detection 
of BVDV by RT-PCR on the trans-tracheal washed is 
greater than those made from blood leukocytes due to 
the restriction of the inflammatory process in lungs.
The susceptibility for Pasteurella multocida 
infection found in this report could be promoted for 
BVDV prime-infection. The association between 
BVDV and Pasteurella multocida was also identified in 
material from nasal swab by RT-PCR in healthy heifers 
[8]. Probably no virus involved with BRD has received 
as much research attention since 1983 as BVDV [17]. 
The immunossupressive nature of BVDV is a critical 
factor in the interaction of BVDV with others viruses 
and bacteria, especially in BRD [4,6]. 
The role of BVDV in mixed infections in re-
spiratory tract is not yet fully elucidated, inquiring if 
the main importance of this agent in the respiratory 
environment is linked only to its immunosuppressive 
action due to infection of leukocytes that participate 
in innate and specific immune response of mucous in 
respiratory tract [6]. 
High levels of serum antibodies were detected 
for BVDV and BRSV in the investigated heifers; how-
ever, 3 calves had antibody titers to BHV-1 below of the 
protective value equivalent to 32. It is not possible to af-
firm that the antibodies detected in the serum neutraliza-
tion were obtained passively by ingestion of colostrum 
or because of active immunity due to the circulation of 
the virus in the herd. The presence of maternal antibod-
ies makes unfeasible the use of serum neutralization for 
the diagnosis of BVDV before 10 weeks of life [11].
The BVDV detection in trans-tracheal lavage 
was the first evidence of the BVDV infection in this herd. 
Among 2013 to 2016, others events were happening 
enforce the evidence of PI’s presence in the farm, such 
as seropositive calves identification before colostrum 
intake [13]; and high levels of specific antibodies for 
BVDV in the bulk tank milk. These facts motivated the 
technical team and producers to invest in PI screening.
The rate of PI’s observed was low (0.81%), 
comparing with the values reported in the literature 
(1-2%) [16]. The intensive vaccination and colostrum 
management of this farm could be protected the herd 
against BVDV, however others facts facilitated the 
introduction of the virus in the herd. This research was 
conduced in a high-production dairy farm with around 
3,700 animals raised in an open herd, in which some 
of cows with high genetic potential were transferred 
for embryo collection in Paraná, Brazil, resulting in 
the addition of the calves to the herd by others routes. 
In addition, the farm used for many years vaccine 
containing only BVDV-1, which may have favored the 
entry and spread of BVDV-2 or BVDV-3 in the herd. 
The main cause of cull in PI animals during this 
study was bronchopneumonia. It is worth remember-
ing that one of the animals diagnosed as PI during the 
screening of herd had presented positive RT-PCR for 
BVDV in trans-tracheal lavage. The farmers main-
tained these heifers in the herd from 2013 up to 2016, 
when the diagnosis of PI was realized. 
BRD is certainly one of the most important dis-
eases in the world, so it is very important to know the main 
risk factors and etiologic agents involved in etiopatho-
genesis of the disease for the establishment of treatment 
protocols, and more efficient and specific prevention and 
control protocols. Generally, treatment protocols are based 
on the use of antibiotics, although viruses may represent 
the primary cause of bronchopneumonia. This research 
showed the presence of BVDV trans-tracheal lavage in 
heifers presenting bronchopneumonia by RT-PCR. This 
fact points to the need for BRD control programs that 
include detection of PI animals.
CONCLUSION
The identification of BVDV in trans-tracheal 
lavage by RT-PCR in heifers manifesting bronchopneu-
monia could be used to prove the involvement of this 
virus in BRD complex. It could be considered an alert to 
perform the screening of PI’s in the herd to directly control 
of BVDV and indirectly control of secondary agents.
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